Skip to content

Clinical trials

Anemia, Refractory, with Excess of Blasts trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Country / region: United States Clear all

242 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200016
200112
200213
20039
200415
200513
200610
200714
20084
20098
201010
20115
20125
20139
20146
20155
20164
20174
20187
20195
20203
20223
20233
20241
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed160
Terminated39
Recruiting19
Active, not recruiting10
Unknown status7
Withdrawn4
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)26
Fred Hutchinson Cancer Center25
Masonic Cancer Center, University of Minnesota11
Memorial Sloan Kettering Cancer Center11
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins11
M.D. Anderson Cancer Center9
Case Comprehensive Cancer Center8
National Heart, Lung, and Blood Institute (NHLBI)7
University of California, San Francisco7
Roswell Park Cancer Institute5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts242
Leukemia, Myeloid, Acute137
Myelodysplastic Syndromes135
Leukemia120
Leukemia, Myelomonocytic, Chronic112
Precursor Cell Lymphoblastic Leukemia-Lymphoma103
Anemia, Refractory69
Myeloproliferative Disorders69
Congenital Abnormalities58
Leukemia, Lymphocytic, Chronic, B-Cell58

Trials

Showing 1 to 25 of 242. Each trial links to its page on Pharma Observatory.

142 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.